Paralysis Treatment Innovation Market

Regenerative therapies lead the paralysis treatment innovation market with a 35.0% share in 2026 by treatment type, followed by brain-computer interfaces at 42.5% by technology and spinal cord injury at 37.0% by indication. Adoption reflects advances in restorative therapies, while complex clinical validation and high development costs remain key constraints.